Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neuroendocrine Tumors × vatalanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Glioblastoma 3 Central Nervous System Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Somatostatinoma 2 Sarcoma 2 Prostatic Neoplasms 2 Neoplasms, Plasma Cell 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Insulinoma 2 Glucagonoma 2 Gliosarcoma 2 Gastrinoma 2 Carcinoma, Renal Cell 2 Carcinoma, Islet Cell 2 Brain Neoplasms 2 von Hippel-Lindau Disease 1 Vipoma 1 Uterine Cervical Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Solitary Fibrous Tumor, Pleural 1 Rectal Neoplasms 1 Primary Myelofibrosis 1 Pheochromocytoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1

Interventions

lutetium Lu 177 dotatate 33 Everolimus 29 Magnetic Resonance Spectroscopy 13 lanreotide 12 gallium Ga 68 dotatate 12 Temozolomide 11 Octreotide 11 Capecitabine 11 Nivolumab 10 177Lu-octreotide, DOTA(0)-Tyr(3)- 10 surufatinib 8 pembrolizumab 8 cabozantinib 8 Positron Emission Tomography Computed Tomography 8 3-Iodobenzylguanidine 8 Sunitinib 7 Specimen Handling 7 amino-acid, glucose, and electrolyte solution 6 90Y-octreotide, DOTA-Tyr(3)- 6 pasireotide 5 Lutetium-177 5 Fluorodeoxyglucose F18 5 Carboplatin 5 Bevacizumab 5 olaparib 4 avelumab 4 Somatostatin 4 Ipilimumab 4 Injections 4 Etoposide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00590343 2011-06-29

PTK787

Louisiana State University Health Sciences Center in New Orleans

Phase 2 Completed

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡